Inventor · disambiguated record
Lillian Chiang
Also filed as: CHIANG LILLIAN · CHIANG LILLIAN W · CHIANG LILLIAN WEI-MING
8 granted patents·14 pending applications·101 citations·filing 2001–2022
82Inventor score
Files withEVRYS BIO LLC6MILLENNIUM PHARM INC6CHIANG LILLIAN W4FORGE LIFE SCIENCE LLC2KADMON CORP LLC2
Top patents by PatentIndex Score
22 records- 0196US7029895B227411, a novel human PGP synthaseMILLENNIUM PHARM INC·Filed 2003·Granted Apr 18, 2006·96 cites·10 claims
- 0276US11459321B2Broad spectrum antiviral compositions and methodsEVRYS BIO LLC·Filed 2018·Granted Oct 4, 2022·2 cites·21 claims
- 0376US11358961B2Anti-HCMV compositions and methodsEVRYS BIO LLC·Filed 2019·Granted Jun 14, 2022·1 cites·15 claims
- 0476US10556894B2Anti-HCMV compositions and methodsFORGE LIFE SCIENCE LLC·Filed 2015·Granted Feb 11, 2020·2 cites·24 claims
- 0571US12459935B2Broad spectrum antiviral compositions and methodsEVRYS BIO LLC·Filed 2022·Granted Nov 4, 2025·0 cites·19 claims
- 0668US2022135556A1Anti-hcmv compositions and methodsEVRYS BIO LLC·Filed 2022·Application pending·0 cites
- 0755US2024109883A1Anti-Tumor Compositions and MethodsEVRYS BIO LLC·Filed 2021·Application pending·0 cites
- 0854US2021040049A1Anti-hcmv compositions and methodsEVRYS BIO LLC·Filed 2020·Application pending·0 cites
- 0953US2015010545A1Methods for treatment of breast cancer nonresponsive to trastuzumabKADMON CORP LLC·Filed 2012·Application pending·0 cites
- 1048US2010076037A1Methods of Treating Neuropathic Pain with Agonists of PPAR-gammaCHIANG LILLIAN W·Filed 2007·Application pending·0 cites
- 1148US2010222304A1Methods of Treating Neuropathic Pain by Modulation of Glycogenolysis or GlycolysisCHIANG LILLIAN W·Filed 2007·Application pending·0 cites
- 1246US10723708B2Anti-HCMV compositions and methodsFORGE LIFE SCIENCE LLC·Filed 2015·Granted Jul 28, 2020·0 cites·14 claims
- 1345US2005222027A1Modulation of complement to treat painEURO CELTIQUE SA·Filed 2004·Application pending·0 cites
- 1444US9586940B2Methods for treatment of breast cancer nonresponsive to trastuzumabKADMON CORP LLC·Filed 2015·Granted Mar 7, 2017·0 cites·10 claims
- 1544US2003165863A1NARC10 and NARC16, programmed cell death-associated molecules and uses thereofMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 1643US2014024692A1Methods of Treating Neuropathic Pain with Benzimidazole Derivative Agonists of PPARgammaCHIANG LILLIAN W·Filed 2013·Application pending·0 cites
- 1743US2003119038A1NARC1, novel subtilase-like homologsFiled 2002·Application pending·0 cites
- 1842US2011230392A1Novel narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, and narc 25 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2011·Application pending·0 cites
- 1941US8563589B2Methods of treating neuropathic pain with benzimidazole derivative agonists of PPARgammaCHIANG LILLIAN W·Filed 2010·Granted Oct 22, 2013·0 cites·3 claims
- 2041US2002081679A1NARC8 programmed cell-death-associated molecules and uses thereofMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 2140US2002115185A1Neuronal cell death associated molecules and uses thereforMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 2236US2010291099A1Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lillian Chiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →